HIGHLIGHTS
- who: Nam Kyeong Kim et al. from the Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam have published the research: Feasibility of extended cycles of neoadjuvant chemotherapy in patients with advanced ovarian cancer in terms of prognosis and surgical outcomes, in the Journal: PLOS ONE of January/26,/2023
- what: The authors aimed to identify the effect of an extended number of neoadjuvant chemotherapy (NAC) cycles on prognosis and surgical morbidity after interval debulking surgery (IDS) in patients with newly diagnosed advanced ovarian cancer. Main findings of the study This study showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.